PR91299

SAN FRANCISCO and CARY, N.C., Aug. 25, 2021 /PRNewswire=KYODO JBN/ --

  -- Integration of data capture and transactions ensures that the site

     and subject stay together in a unified workflow

endpoint Clinical (https://c212.net/c/link/?t=0&l=en&o=3269693-1&h=4205405233&u=https%3A%2F%2Fwww.endpointclinical.com%2Firt-solution%2F&a=endpoint+Clinical), the leader in global interactive response technology (IRT(R)) for clinical trials, and THREAD (https://c212.net/c/link/?t=0&l=en&o=3269693-1&h=2038022612&u=https%3A%2F%2Fwww.threadresearch.com%2F&a=THREAD), a leading technology and service provider enabling decentralized clinical

trials (DCT), have announced their partnership to offer sponsors and sites a

solution that simplifies DCT operations and reduces research study timelines.

"Adoption of DCT technologies that are capable of not only performing

individually as best-in-class solutions but are also designed and engineered to

be at optimal performance in an integrated clinical data mesh are the key to

meeting demands and leading in the rapidly changing landscape of clinical

trials," says Brad Cottreau, Vice President of Global Sales at endpoint

Clinical.

This ecosystem approach realizes the full potential of critical functions such

as telehealth visits and direct-to-patient/home health shipping of study drugs,

all while maintaining mission-critical goals of high patient engagement,

compliance, and retention.

Through this partnership, endpoint Clinical and THREAD provide two-way

integration for eConsent, screening, and randomization, supporting automation

of underlying workflows across the two platforms. The interfacing of systems

has a particular impact on sites, as they do not need to duplicate data entry.

In addition, this integrated approach simplifies operations such as subject

creation, screening, assessments, randomization (including dispensing), and

subject treatment visits. Two-way communication between the platforms enables

data-driven, rapid feedback that can inform strategies for patient recruitment,

supply procurement, clinical operations, and data management. Together, this

results in cleaner data and a faster study close.

"As decentralized trials continue to propel global scalability and flexibility

of clinical trials, THREAD partners with clients to ensure a seamless execution

from study design to close-out via our single, comprehensive platform," said

John Reites, CEO of THREAD. "Our collaboration with endpoint represents a new

way to synchronize the real-world experience of the participant with the data

at the site, resulting in one smooth continuum."

"When establishing partnerships with other world-class technology providers,

such as THREAD, we always first address how the solution we offer can solve

pain points for sponsors," said Christine Oliver, CEO of endpoint. "Beyond

addressing pain points, we're also pushing the boundaries of what the market

has been able to do to date to evolve the way we manage trials and continue to

increase speed and efficiency for sponsors."

About endpoint

endpoint is an interactive response technology (IRT(R)) systems and solutions

provider that supports the life sciences industry. For the past decade, their

customer-obsessed team of professionals has been continuously evolving their

suite of technologies to help Sponsors achieve clinical trial success. Their

dynamic IRT solution, PULSE(R), for patient randomization and management, site

management, and drug supply management and leading-edge clinical supplies

management tool, DRIVE, has proven to maximize the supply chain and minimize

operational costs, and ensure timely and accurate patient dosing. endpoint is

headquartered in San Francisco, California, with offices across the US, EU, and

Asia. www.endpointclinical.com

About THREAD

THREAD is a leading provider of a proprietary, decentralized research platform

and suite of supporting services used by biopharma, CROs, and life science

organizations to remotely capture data from participants and sites during,

in-between, and in lieu of in-clinic visits. THREAD's platform and supporting

services are helping customers to shorten study launch timelines, reduce study

budgets with Virtual Visits, and bring studies from the clinic to patients'

homes. THREAD provides key platform features such as eConsent, eCOA/ePRO,

sensors, reminders, and telehealth virtual visits to support remote data

capture, hybrid virtual studies, and fully decentralized studies in key

therapeutic areas. In 2019, THREAD was acquired by strategic health care

investors Water Street Healthcare Partners and JLL Partners. Visit

www.THREADresearch.com to learn more.

Contacts:

Catherine Ditzler

Associate Director of Marketing

endpoint Clinical

1-415-688-3424

e: cditzler@endpointclinical.com

Kristin Schaeffer

PR Director

THREAD

1-858-354-8850

e: kschaeffer@cglife.com

Source - endpoint Clinical